Advanced Biomed Common Stock Statistics
Share Statistics
Advanced Biomed Common Stock has 21.64M
shares outstanding. The number of shares has increased by null%
in one year.
| Shares Outstanding | 21.64M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 1,512 |
| FTD / Avg. Volume | 1.58% |
Short Selling Information
The latest short interest is 8.22K, so 0.04% of the outstanding
shares have been sold short.
| Short Interest | 8.22K |
| Short % of Shares Out | 0.04% |
| Short % of Float | 0.09% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -26.24 and the forward
PE ratio is null.
Advanced Biomed Common Stock's PEG ratio is
1.
| PE Ratio | -26.24 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 43.89 |
| P/FCF Ratio | -33.18 |
| PEG Ratio | 1 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Advanced Biomed Common Stock.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.12,
with a Debt / Equity ratio of 0.08.
| Current Ratio | 1.12 |
| Quick Ratio | 1.12 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | -0.06 |
| Debt / FCF | -0.06 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-69,556.95 |
| Employee Count | 40 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by null% in the
last 52 weeks. The beta is 0, so Advanced Biomed Common Stock's
price volatility has been lower than the market average.
| Beta | 0 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 35.81 |
| Average Volume (20 Days) | 95,645 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -2.54M |
| Net Income | -2.78M |
| EBITDA | -2.14M |
| EBIT | -2.54M |
| Earnings Per Share (EPS) | -0.14 |
Full Income StatementBalance Sheet
The company has 2.61M in cash and 126.74K in
debt, giving a net cash position of 2.48M.
| Cash & Cash Equivalents | 2.61M |
| Total Debt | 126.74K |
| Net Cash | 2.48M |
| Retained Earnings | -15.97M |
| Total Assets | 4.5M |
| Working Capital | -689.9K |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -2.13M
and capital expenditures -74.11K, giving a free cash flow of -2.2M.
| Operating Cash Flow | -2.13M |
| Capital Expenditures | -74.11K |
| Free Cash Flow | -2.2M |
| FCF Per Share | -0.11 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
